Back

Clinical outcomes of drug-coated balloon angioplasty with or without Jetstream atherectomy for severely calcified femoropopliteal lesions: a Japanese real-world study

29 August 2026 (16:15 - 16:45)
Organised by: Logo
Congress Presentation Part of: Carotid and peripheral artery disease Carotid and Peripheral Arteries ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Motoaki Kai

Shonan Kamakura General Hospital, Kamakura (Japan)

3 More presentations in this session

Presentation thumbnail
Safety and clinical outcomes of neuroprotected, patient-tailored Carotid Artery Stenting: A prospective single-center cohort
Mr F. Toulgaridis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
A biomimetic, bioengineered polymeric pulmonary valve promotes native tissue remodeling and thrombosis-free function in a chronic ovine model
Doctor G. d'ancona (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Enhanced recovery after cardiac surgery implementation enables rapid postoperative recovery with excellent safety: results from an initial minimally invasive cohort
Doctor X. Xiong (Cologne, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Carotid and peripheral artery disease

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative evaluation of one-year outcomes between stent and non-stent strategies following atherectomy for severely calcified coronary lesions
29 August 2026
thumbnail
Congress Presentation
Intravascular ultrasound-guided endovascular treatment for deep vein thrombosis: a multicenter study from Japan
31 August 2025
thumbnail
Congress Presentation
Clinical outcomes and risk factors associated with drug-coated balloon treatment for femoropopliteal artery disease in patients on maintenance hemodialysis
25 August 2023
thumbnail
Congress Presentation
Impact of lipid-rich plaques in femoropopliteal artery on limb outcomes in patients receiving endovascular therapy
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources